Literature DB >> 21593163

The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence.

Erika De León Vázquez1, Kenneth M Kaye.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a 1,162-amino-acid protein that acts on viral terminal repeat (TR) DNA to mediate KSHV episome persistence. The two essential components of episome persistence are DNA replication prior to cell division and episome segregation to daughter nuclei. These functions are located within N- and C-terminal regions of LANA. N- and C-terminal regions of LANA are sufficient for TR DNA replication. In addition, N- and C-terminal regions of LANA tether episomes to mitotic chromosomes to segregate episomes to progeny cell nuclei. To generate a tethering mechanism, N-terminal LANA binds histones H2A/H2B to attach to mitotic chromosomes, and C-terminal LANA binds TR DNA and also associates with mitotic chromosomes. Here, we test the importance of the internal LANA sequence for episome persistence. We generated LANA mutants that contain N- and C-terminal regions of LANA but have most of the internal sequence deleted. As expected, the LANA mutants bound mitotic chromosomes in a wild-type pattern and also bound TR DNA as assayed by electrophoretic mobility shift assays (EMSA). The mutants mediated TR DNA replication, although with reduced efficiency compared with LANA. Despite the ability to replicate DNA and exert the chromosome and DNA binding functions necessary for segregating episomes to daughter nuclei, the mutants were highly deficient for the ability to mediate both short- and long-term episome persistence. These data indicate that internal LANA sequence exerts a critical effect on its ability to maintain episomes, possibly through effects on TR DNA replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593163      PMCID: PMC3147901          DOI: 10.1128/JVI.00304-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.

Authors:  G M Platt; G R Simpson; S Mittnacht; T F Schulz
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions.

Authors:  Karin Mattsson; Csaba Kiss; Georgina M Platt; Guy R Simpson; Elena Kashuba; George Klein; Thomas F Schulz; Laszlo Szekely
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

3.  Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.

Authors:  T Piolot; M Tramier; M Coppey; J C Nicolas; V Marechal
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

5.  DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  A C Garber; M A Shu; J Hu; R Renne
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Lim; Y Gwack; S Hwang; S Kim; J Choe
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

7.  The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence.

Authors:  Andrew J Barbera; Mary E Ballestas; Kenneth M Kaye
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Transcriptional coactivation of c-Jun by the KSHV-encoded LANA.

Authors:  Jiabin An; Yiping Sun; Matthew B Rettig
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

9.  KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.

Authors:  Takashi Komatsu; Mary E Ballestas; Andrew J Barbera; Brenna Kelley-Clarke; Kenneth M Kaye
Journal:  Virology       Date:  2004-02-20       Impact factor: 3.616

10.  HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus.

Authors:  György Stuber; Karin Mattsson; Emilie Flaberg; Emrah Kati; Laszlo Markasz; Julie A Sheldon; George Klein; Thomas F Schulz; Laszlo Szekely
Journal:  Mol Cancer       Date:  2007-04-13       Impact factor: 27.401

View more
  26 in total

1.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

3.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

4.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

5.  Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.

Authors:  Franceline Juillard; Erika De León Vázquez; Min Tan; Shijun Li; Kenneth M Kaye
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 6.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.

Authors:  Magdalena Weidner-Glunde; Giuseppe Mariggiò; Thomas F Schulz
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

7.  Latency-Associated Nuclear Antigen E3 Ubiquitin Ligase Activity Impacts Gammaherpesvirus-Driven Germinal Center B Cell Proliferation.

Authors:  Sofia A Cerqueira; Min Tan; Shijun Li; Franceline Juillard; Colin E McVey; Kenneth M Kaye; J Pedro Simas
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import.

Authors:  Kellie Howard; Lidia Cherezova; Laura K DeMaster; Timothy M Rose
Journal:  Virology       Date:  2017-08-29       Impact factor: 3.616

10.  Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence.

Authors:  Aline C Habison; Chantal Beauchemin; J Pedro Simas; Edward J Usherwood; Kenneth M Kaye
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.